Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Madrigal Pharmaceuticals
MDGL
$11.9B
| $1.36M | ﹤0.01% |
17,111
-35,871
| -68% | -$3.1M |
|
2377
Vanguard Consumer Discretionary ETF
VCR
$6.3B
| $1.36M | ﹤0.01% |
4,400
-6,400
| -59% | -$2.03M |
|
2378
MP Materials
MP
$8.55B
| $1.36M | ﹤0.01% |
+42,300
| New | +$1.47M |
|
2379
iShares Core S&P US Growth ETF
IUSG
$33.5B
| $1.36M | ﹤0.01% |
+13,300
| New | +$1.4M |
|
2380
Farmers & Merchants Bancorp
FMAO
$471M
| $1.36M | ﹤0.01% |
60,581
-36,498
| -38% | -$817K |
|
2381
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $1.35M | ﹤0.01% |
9,700
-3,800
| -28% | -$540K |
|
2382
AdvisorShares Pure US Cannabis ETF
MSOS
$812M
| $1.35M | ﹤0.01% |
+42,700
| New | +$1.48M |
|
2383
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.35M | ﹤0.01% |
36,853
+8,453
| +30% | +$311K |
|
2384
Vanguard High Dividend Yield ETF
VYM
$82.6B
| $1.34M | ﹤0.01% |
+13,000
| New | +$1.37M |
|
|
ATTO
2385
DELISTED
Atento S.A.
ATTO
| $1.34M | ﹤0.01% |
47,523
+7,780
| +20% | +$200K |
|
2386
Matthews International
MATW
$856M
| $1.34M | ﹤0.01% |
38,553
-19,628
| -34% | -$674K |
|
2387
Talkspace
TALK
$874M
| $1.34M | ﹤0.01% |
+366,323
| New | +$2.01M |
|
|
OYST
2388
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $1.33M | ﹤0.01% |
+112,300
| New | +$1.64M |
|
2389
Passage Bio
PASG
$14.8M
| $1.33M | ﹤0.01% |
6,660
+3,445
| +107% | +$821K |
|
2390
Sprott Uranium Miners ETF
URNM
$1.91B
| $1.33M | ﹤0.01% |
+34,528
| New | +$1.12M |
|
2391
Artisan Partners
APAM
$3.04B
| $1.33M | ﹤0.01% |
27,100
-175,619
| -87% | -$8.86M |
|
|
DVD
2392
DELISTED
Dover Motorsports
DVD
| $1.31M | ﹤0.01% |
543,236
-50,786
| -9% | -$125K |
|
2393
Invesco FTSE RAFI US 1000 ETF
PRF
$9.98B
| $1.31M | ﹤0.01% |
41,500
+15,000
| +57% | +$485K |
|
2394
RLI Corp
RLI
$5.76B
| $1.31M | ﹤0.01% |
26,200
+9,928
| +61% | +$528K |
|
2395
Minerva Neurosciences
NERV
$202M
| $1.31M | ﹤0.01% |
94,265
-30,966
| -25% | -$466K |
|
2396
Mustang Bio
MBIO
$4.52M
| $1.31M | ﹤0.01% |
650
+630
| +3,150% | +$1.35M |
|
2397
Merchants Bancorp
MBIN
$2.56B
| $1.31M | ﹤0.01% |
49,800
+12,000
| +32% | +$298K |
|
2398
Barnwell Industries
BRN
$14.3M
| $1.31M | ﹤0.01% |
432,168
-291,376
| -40% | -$708K |
|
2399
Bio-Techne
TECH
$11.2B
| $1.31M | ﹤0.01% |
10,800
-23,600
| -69% | -$2.87M |
|
|
CBIO
2400
Crescent Biopharma
CBIO
$585M
| $1.3M | ﹤0.01% |
5,961
-1,616
| -21% | -$342K |
|
Similar funds
Renaissance Technologies's Q3 2021 Portfolio in Review
As of Q3 2021, Renaissance Technologies held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Renaissance Technologies's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Renaissance Technologies added most to Nike in Q3 2021, an estimated $453M increase.
- Renaissance Technologies's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Renaissance Technologies fully exited Amazon in Q3 2021, selling an estimated $897M.
- Renaissance Technologies's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Renaissance Technologies opened 663 new positions and closed 653 in Q3 2021.
- Renaissance Technologies's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.